In the current study, we investigated the cytotoxic and antitumor potential of N-allyl-BS and N-(3-mb)-BS against two phenotypically different cancer cell lines, the PTEN-positive DU145 cells and PTEN-negative PC-3 cells, and against a healthy epithelial cell line PNT1A. The gene discussed is PTEN; the disease is cancer.